New Era Alkaloids Stock Price Analysis and Quick Research Report. Is New Era Alkaloids an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse New Era Alkaloids. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). New Era Alkaloids has a PE ratio of 0 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. New Era Alkaloids has ROA of 0.678614970246244% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. New Era Alkaloids has a Current ratio of 4.64348925410872.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. New Era Alkaloids has a ROE of 2.36350744504845%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. New Era Alkaloids has a Debt to Equity ratio of 1.7603 which means that the company has low proportion of debt in its capital.

• Sales growth: New Era Alkaloids has reported revenue growth of -80.2551640340219% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of New Era Alkaloids for the current financial year is -179.230769230769%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for New Era Alkaloids is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of New Era Alkaloids is Rs 0. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of New Era Alkaloids in Ticker for free. Also, one can get the intrinsic value of New Era Alkaloids by using Valuation Calculators, which are available with a Finology ONE subscription. 

New Era Alkaloids FAQs

Q1. What is New Era Alkaloids share price today?
Ans: The current share price of New Era Alkaloids is Rs 0.

Q2. What is the market capitalisation of New Era Alkaloids?
Ans: New Era Alkaloids has a market capitalisation of Rs 0 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of New Era Alkaloids?
Ans: The PE ratio of New Era Alkaloids is 0 and the P/B ratio of New Era Alkaloids is 0, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of New Era Alkaloids share?
Ans: The 52-week high share price of New Era Alkaloids is Rs 0, and the 52-week low share price of New Era Alkaloids is Rs 0.

Q5. Does New Era Alkaloids pay dividends?
Ans: Currently, New Era Alkaloids does not pay dividends. Dividend yield of New Era Alkaloids is around 0%.

Q6. What are the face value and book value of New Era Alkaloids shares?
Ans: The face value of New Era Alkaloids shares is Rs 10, while the book value per share of New Era Alkaloids is around Rs 0. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of New Era Alkaloids?
Ans: New Era Alkaloids has a total debt of Rs 11.6261 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of New Era Alkaloids?
Ans: The ROE of New Era Alkaloids is 2.36350744504845% and ROCE of New Era Alkaloids is 0.522451899144068%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is New Era Alkaloids a good buy for the long term?
Ans: The New Era Alkaloids long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is New Era Alkaloids undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the New Era Alkaloids appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check New Era Alkaloids’s financials?
Ans: You can review New Era Alkaloids’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.